Screening for rheumatoid arthritis with finger joint power Doppler ultrasonography: quantification of conventional power Doppler ultrasonographic scoring

被引:22
作者
Fukae, Jun [2 ]
Shimizu, Masato [2 ]
Kon, Yujiro [2 ]
Tanimura, Kazuhide [2 ]
Matsuhashi, Megumi [2 ]
Kamishima, Tamotsu [3 ]
Koike, Takao [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Med 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Tokeidai Mem Hosp, Ctr Rheumat Dis, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ Hosp, Dept Radiol, Sapporo, Hokkaido 060, Japan
关键词
Diagnosis; Power Doppler ultrasonography; Quantitative scoring method; Rheumatoid arthritis; Synovial vascularity; CONTROLLED-TRIAL; ULTRASOUND; METHOTREXATE; THERAPY; DISEASE; RADIOGRAPHY; INFLIXIMAB; SONOGRAPHY; REMISSION; SYNOVITIS;
D O I
10.1007/s10165-009-0190-0
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Power Doppler ultrasonography (PD-US) has proved to be a useful technique to measure synovial vascularity due to its capability to provide data that can be used to evaluate the level of joint inflammation and assess rheumatoid arthritis (RA). We have developed a novel PD-US finger joint scoring method that introduces quantitative measurements into the conventional PD-US assessment method. A comparison of the two methods revealed that our novel PD-US method strongly correlates with the conventional method in terms of RA assessment. We performed finger joint PD-US on 69 patients with RA and 70 patients who had multiple joint pain but showed no evidence of inflammatory diseases (non-inflammatory disease, NI) and measured the synovial vascularity of the metacarpophalangeal joints 1-5 and proximal interphalangeal (PIP) joints 1-5 for each patient. We analyzed the data with receiver operating characteristic analysis and, based on the results for the total vascularity of 20 finger joints, defined a cut-off value of 36% as discriminating between RA and NI. This cut-off value was found to be a valuable tool in screening for RA. We conclude that our finger joint PD-US scoring system is both useful and applicable for diagnosing RA.
引用
收藏
页码:502 / 506
页数:5
相关论文
共 23 条
[1]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]
Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO
[3]
2-3
[4]
An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis [J].
Brown, A. K. ;
Conaghan, P. G. ;
Karim, Z. ;
Quinn, M. A. ;
Ikeda, K. ;
Peterfy, C. G. ;
Hensor, E. ;
Wakefield, R. J. ;
O'Connor, P. J. ;
Emery, P. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (10) :2958-2967
[5]
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial [J].
Clair, EWS ;
van der Heijde, DMFM ;
Smolen, JS ;
Maini, RN ;
Bathon, JM ;
Emery, P ;
Keystone, E ;
Schiff, M ;
Kalden, JR ;
Wang, B ;
DeWoody, K ;
Weiss, R ;
Baker, D .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3432-3443
[6]
Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]
[7]
Grassi W, 2003, CLIN EXP RHEUMATOL, V21, P424
[8]
The relation between composite ultrasound measures and the DAS28 score, its components and acute phase markers in adult RA [J].
Hameed, S. ;
Pilcher, J. ;
Heron, C. ;
Kiely, P. D. W. .
RHEUMATOLOGY, 2008, 47 (04) :476-480
[9]
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) [J].
Hetland, M. L. ;
Ejbjerg, B. ;
Horslev-Petersen, K. ;
Jacobsen, S. ;
Vestergaard, A. ;
Jurik, A. G. ;
Stengaard-Pedersen, K. ;
Junker, P. ;
Lottenburger, T. ;
Hansen, I. ;
Andersen, L. S. ;
Tarp, U. ;
Skjodt, H. ;
Pedersen, J. K. ;
Majgaard, O. ;
Svendsen, A. J. ;
Ellingsen, T. ;
Lindegaard, H. ;
Christensen, A. F. ;
Vallo, J. ;
Torfing, T. ;
Narvestad, E. ;
Thomsen, H. S. ;
Ostergaard, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (03) :384-390
[10]
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].
Maini, R ;
St Clair, EW ;
Breedveld, F ;
Furst, D ;
Kalden, J ;
Weisman, M ;
Smolen, J ;
Emery, P ;
Harriman, G ;
Feldmann, M ;
Lipsky, P .
LANCET, 1999, 354 (9194) :1932-1939